Member Info for roger65

Tks jenkoo. Any thoughts on why G Mayhew pumped £300k of his own money into this at 1.5p? If the BODs here know they can’t deliver revenue then what on Earth was this particular Director thinking?

Ah sorry Rotherby1. You’re right of course. I’ve invested in a company and then I shouldn’t have any doubts and certainly shouldn’t voice any concerns as I start to see my investment slowly disappear. For a minute there PJ’s excitement was contagious. How naive of me.

Shakin - no one wants or needs the GDR PoC test! Anywhere that requires testing already has something in place and I honestly can’t see organisations now shelling out loads of money on new kit when most believe this might just be another wave that will ride itself out in 3 months or so. I couldn’t even tell you what the most up to date Govt advice is to people who realise they’ve tested positive.

Forsy- I agree about a placing early in the New Year once Buddy boy has nailed his salary for another year but I can’t for a minute imagine who would back GDR at such a low price without guarantees of future sales, and if there are any of those then we - the market and all share holders - would have to be told about them. In that scenario the sp would not drop but slowly creep north and Budd could get a better price for a placing.

Just my humble opinion but I think a raise is on the cards sooner than many think owing to the fact revenue from sales is still a long way off . Either that or we get an offer to buy us out the minute that NICE guidance for best practice is published. My money is on an offer of approx 50p. I think that would be voted for but it would be my sincere hope another organisation would realise that’s peanuts and come in with a counter offer. Eventually I’d like to see GDR sold for about 90p but that’s probably fantasy land.

Let’s hope POW at Molopo is next….

Which will sadly not have any bearing on the sp here. Confidence in Fortune has rather drained away of late, hence the steady decline over the last six months irrespective of V prices or exchange rates.

nothing PJ can say, tweet or even RNS to get the sp back on the rise.

Realistically another 6 weeks to two months before we have some proper results? How much further can the sp drop in that time? Anyone expecting to hit 1p again?

Covid is done and dusted as far as GDR is concerned. We know there will be negligible sales (if any) and we certainly won't be told exactly how low the sales figures are just so Budd can say something like 'sales are picking up but slower than we anticipated...'

We also know the sales figures for AIHL will pretty much be zero as even Budd admitted he's awaiting NICE guidance on Best Practice before nation wide adoption of the machines in the NHS. It's going to be a grim update - which is now overdue on his own statement of 'six months' - but Budd simply has to come up with something positive or else the sp will tank and the opportunity to do a placing will disappear altogether.

Come on David Budd and Dr Ian Gilham, share holders are awaiting an update as promised at the end of March. We were told we would be given updates on sales as appropriate over the next six months. We've heard nothing at all other than the NICE guidance being fast tracked and AIHL being submitted for US approvals, firstly to see which route the product must take eg De Novo. I really don't want to see the sp dip under 10p but the longer we wait for anything positive from the CEO's lips the more I worry he simply has nothing good to tell the market and we'll have to hold our collective breath until February until we get back to the low teens.

Gotta say this CEO is desperately poor at comms for share holders and he really shouldn't hold the position he does in a PLC. Shockingly bad. The Chairman is no better and seems to be hiding under a table somewhere.

Speaking personally and from a non-investing pov I am sad/disappointed that whilst this test awaits fully backing and approvals from NICE more children will inevitably end up with a life of deafness. The test holds no risks at all the new-borns - it's a simple swab taken from the inside of the cheek - but can prove to be massively beneficial. Months and months go by at snail pace and another heaven knows how many children will be administered the wrong antibiotics and condemned to a life with out sound. Seems negligent almost that they can't get this Guidance out even quicker.

DSFLAT - the mere fact you've not relayed any news on sales implies there haven't been any to date but that perhaps they spoke positively about the future ie once the NICE guidance is out and they can piggyback on lots of positive PR.

Personally I am surprised there haven't been any private children's hospitals or health services eg Spire Healthcare that have bought into AIHL. They will have the financial resources to easily take something like this on board and make a virtue of the fact they have it.

pb940 - and what should it be?

The buys will only come once the market sees the official results of the drilling programme. Once it's in black and white as to what they know is in the ground then we'll be off to the races. Hopefully though a JV might be announced well before then to jump start the sp. I know this is a long shot but the notion this current drill could prove to be transformational is enticing for obvs reasons. Then there's Tati and Athabasca to come soon after. Patience is key. I'm not patient but am managing to hold my hand steady and away from the sell button for now but if we start declining further it will be hard to resist the offer of selling and just jumping back in when the sp is another 10/15/20% lower. I think that's why PJ is peppering the market with updates in the hope the sp remains steady. If he needs to do a raise any time soon then that will clearly be easier the higher the sp is.

...stupidly small trades set to deliberately take the sp in a particular direction.

three trades, admittedly only worth roughly £400, take the sp back to .91p after a sell of a similar amount knocked it down to .83.

Then after hours a trade worth less then £1 takes the sp all the way down to .8p

Irritating but glad someone is having fun. Wonder how long it will be before we hear from this BOD again. early March? Hope there's a little pump and dump before then! What a bunch of losers. Lifestyle company par excellence. No way any Director could be voted out or salaries challenged as the Directors hold the vast majority of the shares.

One thing that still intrigues me is how they managed to bamboozle Gavin Mayhew to buy £300k worth of shares at 1.5p when they must have already had an inkling the deal with Bradclad was going t.ts up. Either he's a bit dim or there's just more going on than we know about. Anyway, I'm delighted Gavin must be even more under water than I am.

Your work and effort here DSFLAT is highly commendable but, speaking as one who has been here for nearly three years, please don’t get your hopes up regarding sales of any products, even where there are decent distribution agents in place (think Beckman Coulter…).

My own feeling is that Budd is just waiting for the NICE guidance to be published and the widespread adoption of the tests in the NHS to kick start things. IHC will have a huge catalogue of products it sells and it’s unfortunately likely to be the case that GDR’s AIHL kit is nowhere on their radar for now - too much like hard work for low sales return until NHS gives it the publicity it needs. Then I imagine IHC would piggyback any PR and lift a finger. Until then I don’t expect any sales I’m afraid. Not trolling, just trying to be realistic going on previous achievements by Budd and his incredible sales team.

The next news will reveal just his bad the sales picture is but there will be plenty of focus on imminent news re AIHL and the Stroke Marker tests. Said it many times now but I think we’re going to have quite a serious dip on the next update but then be given something positive to chew on ) possibly submission of AIHL for the US?) that will help Budd get through the AGM and secure his salary for another year. Then with NICE news imminent in February we’ll see a rise in the sp and either a) have another placing or b) receive a takeover bid. NICE publication should ensure AIHL is rolled out nationwide and that will be the start of GDR’s income stream. This together with their technology makes them just too appealing to the bigger fish imho. Snap it up once UK sales are guaranteed but well before the really big bucks come in from the EU or the US.

Whatever happens I believe there’s some good returns to be had from investing in GDR now if your prepared to stick around for 6 - 12 months.

Personally hope we’re bought out for about £50m so I can walk with a modest profit and stick my two biggest and fattest fingers up at the wunder CEO that is David Budd.

Current *drilling* programmes. Fat fingers as per usual…

In current market conditions it’s like asking how long is a piece of string. Three years ago the POW portfolio and current dining programmes Wood have seen share price and mcap at least x10 and it’s a bit of a surprise (to me at least) that there has been considerable and sustained selling here for the last three weeks in spite of every possible hint PJ has thrown out.

If they find a commercially viable amount of nickel then one thing we know for sure is that it will be as PJ said ‘transformational’, regardless of which route he and the team decide to go with it.

…the GDR PoC kit was the only machine to detect this….

https://amp.theguardian.com/science/2022/oct/24/immune-system-evading-hybrid-virus-observed-for-first-time-rsv-and-influenza

DB needs to get on and ask if they can test it. If only….

I’m actually fully aware of that Tray and my understanding, like yours, was it’s pretty much done and dusted and just awaiting signatures. Signatures don’t take that long. Drawing up the agreements does. Go figure. Back to waiting. Nothing to see here before Christmas imho, whilst we watch the sp sorely drop back to a penny.

Why hasn’t PJ gone ahead with the transaction that would result in POW’s interest in this project increase to 87.71% from approx 50% if things are really looking that great?

Anyway, a ‘superconductor’ sounds even better than a ‘very large conductor’ so am still hoping for an upturn here. Trying to be patient.

This is going well then.

What are people expecting from Budd in the next few weeks before the AGM?

Interested to hear thoughts. I'm fairly certain sales results of Covid PoC kit will be next to nothing and we'll be given an update with far more focus on AIHL and the Stroke marker products and development.

As such I'm expecting a bit of a drop before and over Christmas and then some serious accumulating in January as people buy in for the NICE guidance due in February. Irrespective of how good that news is, because this is AIM I think the sp will then drop again but then be followed by a sustained rise as news of some sales and, god forbid, some actual revenue for GDR.

Long long way to go still here imo and I don't for a second believe any of the idiotic ramping suggesting we're heading way north from current levels in the next few days or weeks. That's for the birds.

My money is still on a buyout as soon as it looks as if the NHS will commit to adopting AIHL nationwide. Probably March or April although it could happen as soon February withe the release of the NICE guidance. As soon as there is hard evidence that AIHL will provide serious revenue going forwards then I think one of the big pharmas will make their move. Question is how much for. The later they leave it the higher the purchase price will have to be imo.